Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies
East Midlands Pharmacy CollaborativecontractContracts Finder ↗Ref CF-2533200D0O000000rwimUAASME suitableclosed
Estimated value
£2.8m
Awarded value
—
Suppliers
0
Lots
1
0 awarded
Published
09 Aug 2024
Deadline 11 Oct 2024
Description
This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities
Scope
- Reference
- CF-2533200D0O000000rwimUAA
- Total value
- £2,760,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Apr 2025 to 29 Apr 2027
- CPV classifications
- 85100000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 11 Oct 2024, 11:00 am